15 research outputs found
Patient Reported Outcomes in Early Arthritis Patients
Pathophysiology and treatment of rheumatic disease
Patient Reported Outcomes in Early Arthritis Patients
Pathophysiology and treatment of rheumatic disease
LOW DISEASE ACTIVITY OR DAS-REMISSION AS TREATMENT TARGET IN EARLY RHEUMATOID ARTHRITIS PATIENTS
Pathophysiology and treatment of rheumatic disease
Clinical and Radiological Outcomes Of Two Years Remission Steered Treatment In Early Arthritis Patients
Pathophysiology and treatment of rheumatic disease
Remission After One Year in ACPA Positive and ACPA Negative Patients with Early Arthritis
Remission After One Year in ACPA Positive and ACPA Negative Patients with Early Arthritis
Pathophysiology and treatment of rheumatic disease
OUTCOMES OF TWO YEARS OF REMISSION STEERED TREATMENT IN EARLY ARTHRITIS PATIENTS
Pathophysiology and treatment of rheumatic disease
Clinical and Radiological Outcomes After One Year of Remission Steered Combination Treatment in Patients with Early Rheumatoid and Undifferentiated Arthritis
Pathophysiology and treatment of rheumatic disease
Do we need to lower the cut point of the 2010 ACR/EULAR classification criteria for diagnosing rheumatoid arthritis?
__Objective__ In this study we aimed to evaluate the effect of lowering the cut point of the 2010 criteria to identify more patients with RA among early inflammatory arthritis patients.
__Methods__ We included early arthritis patients from the Rotterdam Early Arthritis Cohort with at least one joint with clinical synovitis and symptoms for <1 year, with no other explanation for their symptoms. The demographic and clinical characteristics of each patient were recorded at baseline. Patients were classified as case or non-case at the 1-year follow-up by the definition used in the development of the 2010 criteria (MTX initiati